Hypoglossal nerve stimulation therapy for obstructive sleep apnea hypopnea syndrome

Abstract

Obstructive sleep apnea hypopnea syndrome(OSAHS) is a clinical and critical disease to health, which the accuratly pathogenesis is not very explicit. The mainstream research suggested that dysfunction of upper airway dilator muscles is one of the hazard factors. Genioglossus innervated by the hypoglossal nerve plays crucial roles. It could expand volume of pharyngeal cavity, and increase airflow rate when stimulate it.With the development of anatomy and physiology, hypoglossal nerve stimulation(HGNS) entered into clinical trials, and had made tremendous progress since 2001. Most of clinical trials show that, it could dramatically improve the smooth general peculiarity of the upper respiratory tract in patients with OSAHS in the sleeping state.